Researchers from our lab and Charité Berlin report new findings on antibody-based approaches against Bundibugyo virus. The work includes two Nature Medicine studies on MBP134 and Paulina’s preprint on the broadly neutralizing antibody B10. » read more
The national immunity platform COVID is entering its third funding period! We are excited to continue this important work and warmly welcome our two new COVIM Project Managers, Lisa and Jonas. » read more
Congratulations to Lutz, who has been honored for his outstanding scientific work with the Robert Koch Foundation’s prestigious Post-doctoral Award in Immunology. » read more
We warmly congratulate Kathi on the successful defense of her doctoral thesis on pre-existing humoral immunity to H5N1 influenza viruses in unexposed individuals. » read more
In spring 2026, Chiara, Sophie and Artem shared their latest research at international Keystone Symposia in the United States and the United Kingdom. » read more
Congratulatiosn to Henning who has been awarded the Loeffler-Frosch Prize 2026 by the German Society for Virology in recognition of his outstanding research on virus-neutralizing antibodies and innovative antibody-based therapies against viral infections. » read more
Their study describes 007, a potent broadly neutralizing HIV-1 antibody targeting a glycan-independent V3 epitope and overcoming common viral escape mutations. » read more
The study shows that neutralizing antibodies against cattle-transmitted H5N1 influenza can already be detected in individuals without prior exposure. » read more
Else Kröner-Fresenius Foundation supports innovative approaches to antibody-mediated HIV immunity. » read more
Julian and Henning were honored by the Medical Faculty of the University of Cologne for outstanding academic achievements in 2024. » read more
